Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
ETNK2 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
ETNK2 Highly specific for ethanolamine phosphorylation. Does not have choline kinase activity. Belongs to the choline/ethanolamine kinase family. 3 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Kinase, other; EC 2.7.1.82; Lipid Metabolism - glycerophospholipid
Cellular Component: cytosol
Molecular Function: ethanolamine kinase activity; ATP binding
Biological Process: in utero embryonic development; phospholipid metabolic process; multicellular organism growth; phosphatidylethanolamine biosynthetic process; glycerophospholipid biosynthetic process; placenta development; post-embryonic development
Reference #:  Q9NVF9 (UniProtKB)
Alt. Names/Synonyms: EKI 2; EKI2; Ethanolamine kinase 2; Ethanolamine kinase-like protein; ETNK2; FLJ10761; HMFT1716
Gene Symbols: ETNK2
Molecular weight: 44,781 Da
Basal Isoelectric point: 6.94  Predict pI for various phosphorylation states
Select Structure to View Below

ETNK2

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  Pfam  |  ENZYME  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 K79 QELRPHWKPEQVRTK
0 1 K208 HNYFTLVKNEINPSL
0 1 K317 HYYLQAQKGMAVTPR
  mouse

 
K78-u RELRPHWkPEQVRTK
K207-u HRYFTLVkDEISPSL
K316-u RYYLEAQkGTAASPR
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.